利润表（信邦制药）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 4,565,355,757.09 | 3,046,569,827.96 | 1,582,449,461.55 | 6,460,841,315.46 | 4,823,207,646.87 | 3,256,476,093.85 | 1,605,127,137.43 |
| 营业收入(元) | 4,565,355,757.09 | 3,046,569,827.96 | 1,582,449,461.55 | 6,460,841,315.46 | 4,823,207,646.87 | 3,256,476,093.85 | 1,605,127,137.43 |
| 二、营业总成本(元) | 4,276,861,231.49 | 2,859,294,464.95 | 1,499,475,395.38 | 6,029,956,602.60 | 4,470,734,285.09 | 3,032,948,961.52 | 1,535,323,707.21 |
| 营业成本(元) | 3,724,210,514.97 | 2,501,166,385.53 | 1,307,202,145.01 | 5,232,265,213.44 | 3,860,569,975.61 | 2,621,581,755.19 | 1,314,183,651.87 |
| 研发费用(元) | 3,824,833.20 | 2,155,422.34 | 865,885.03 | 4,672,953.58 | 2,047,197.90 | 1,666,146.84 | 691,393.55 |
| 营业税金及附加(元) | 18,996,760.34 | 11,885,860.27 | 6,931,141.48 | 27,426,488.11 | 20,837,796.71 | 13,319,215.38 | 6,876,674.16 |
| 销售费用(元) | 229,262,839.63 | 146,659,961.12 | 72,869,443.85 | 343,414,000.78 | 254,852,297.29 | 173,661,310.75 | 85,664,834.87 |
| 管理费用(元) | 287,369,213.50 | 188,429,729.92 | 106,724,419.99 | 394,424,869.40 | 308,012,852.43 | 206,643,266.08 | 116,726,561.70 |
| 财务费用(元) | 13,197,069.85 | 8,997,105.77 | 4,882,360.02 | 27,753,077.29 | 24,414,165.15 | 16,077,267.28 | 11,180,591.06 |
| 其中：利息费用(元) | 18,569,510.71 | 12,593,004.89 | 6,661,506.72 | 39,698,422.94 | 32,365,164.38 | 21,565,345.62 | 13,837,692.03 |
| 其中：利息收入(元) | 6,002,045.76 | 4,035,891.14 | 2,017,147.48 | 12,729,596.56 | 8,585,611.75 | 5,961,018.61 | 2,857,593.16 |
| 三、其他经营收益 | |||||||
| 加：投资收益(元) | 1,300,500.19 | - | - | 9,397,367.33 | -788,943.67 | -2,033,937.67 | 4,566.25 |
| 资产处置收益(元) | -25,311.75 | -9,669.80 | -11,745.36 | 17,801.27 | -55,861.83 | -43,051.54 | -37,882.51 |
| 资产减值损失(元) | - | - | - | -7,523,015.71 | - | - | - |
| 信用减值损失(元) | -25,821,346.09 | -21,706,722.30 | -3,343,367.45 | -53,126,703.33 | -16,734,942.66 | -16,742,002.74 | 251,094.66 |
| 其他收益(元) | 3,296,082.51 | 2,198,410.45 | 977,957.20 | 5,382,978.60 | 4,954,859.81 | 4,053,699.54 | 1,100,465.53 |
| 四、营业利润(元) | 267,244,450.46 | 167,757,381.36 | 80,596,910.56 | 385,033,141.02 | 339,848,473.43 | 208,761,839.92 | 71,121,674.15 |
| 加：营业外收入(元) | 735,020.83 | 595,473.35 | 281,043.64 | 25,010,364.72 | 2,364,102.15 | 1,459,020.11 | 1,217,905.71 |
| 减：营业外支出(元) | 3,707,307.60 | 2,264,885.70 | 1,287,768.48 | 14,021,913.70 | 6,511,746.70 | 1,398,758.17 | 150,047.94 |
| 五、利润总额(元) | 264,272,163.69 | 166,087,969.01 | 79,590,185.72 | 396,021,592.04 | 335,700,828.88 | 208,822,101.86 | 72,189,531.92 |
| 减：所得税费用(元) | 31,534,618.66 | 14,647,709.58 | 7,896,395.34 | 42,249,086.61 | 32,255,423.11 | 17,224,732.35 | 9,541,011.22 |
| 六、净利润(元) | 232,737,545.03 | 151,440,259.43 | 71,693,790.38 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.70 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 232,737,545.03 | 151,440,259.43 | 71,693,790.38 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.70 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 176,589,574.90 | 114,879,289.31 | 58,824,843.56 | 287,232,798.94 | 246,574,999.15 | 156,021,447.29 | 52,944,770.89 |
| 少数股东损益(元) | 56,147,970.13 | 36,560,970.12 | 12,868,946.82 | 66,539,706.49 | 56,870,406.62 | 35,575,922.22 | 9,703,749.81 |
| 扣除非经常性损益后的净利润(元) | 175,237,268.06 | 114,851,463.77 | 58,811,966.40 | 267,902,516.17 | 247,099,219.38 | 155,133,175.63 | 51,274,117.58 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.09 | 0.06 | 0.03 | 0.15 | 0.13 | 0.08 | 0.03 |
| 二、稀释每股收益(元) | 0.09 | 0.06 | 0.03 | 0.15 | 0.13 | 0.08 | 0.03 |
| 九、综合收益总额(元) | 232,737,545.03 | 151,440,259.43 | 71,693,790.38 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.70 |
| 归属于母公司所有者的综合收益总额(元) | 176,589,574.90 | 114,879,289.31 | 58,824,843.56 | 287,232,798.94 | 246,574,999.15 | 156,021,447.29 | 52,944,770.89 |
| 归属于少数股东的综合收益总额(元) | 56,147,970.13 | 36,560,970.12 | 12,868,946.82 | 66,539,706.49 | 56,870,406.62 | 35,575,922.22 | 9,703,749.81 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-29 | 2024-04-16 | 2023-10-30 | 2023-08-29 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 40 of 40 entries